UniPharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	453	431	492	525	550	400
Market Cap Growth	-20.56%	-12.27%	-6.42%	-4.52%	37.73%	-25.33%
Enterprise Value	328	300	371	355	366	214
Last Close Price	12.75	12.15	13.85	14.80	15.50	11.35
Forward PE	-	23.14	23.14	23.14	23.14	23.14
PS Ratio	5.12	4.88	5.26	5.09	4.30	3.79
PB Ratio	1.97	1.88	1.73	1.68	1.82	1.34
P/TBV Ratio	2.00	1.91	1.75	1.69	1.83	1.35
P/FCF Ratio	-	-	-	133.90	-	-
P/OCF Ratio	-	-	-	43.66	-	-
EV/Sales Ratio	3.71	3.39	3.97	3.44	2.86	2.03
EV/FCF Ratio	-8.64	-	-	90.52	-	-
Debt / Equity Ratio	0.05	0.05	0.05	0.00	0.01	0.02
Debt / FCF Ratio	-	-	-	0.07	-	-
Net Debt / Equity Ratio	-0.54	-0.54	-0.50	-0.53	-0.52	-0.57
Net Debt / EBITDA Ratio	3.04	3.04	5.18	6.68	8.44	4.81
Net Debt / FCF Ratio	3.28	3.28	9.42	-42.53	4.95	12.44
Asset Turnover	0.29	0.29	0.28	0.30	0.38	0.28
Inventory Turnover	1.54	1.54	1.75	1.74	1.60	1.50
Quick Ratio	3.96	3.96	5.25	5.08	6.82	4.24
Current Ratio	4.86	4.86	6.03	6.10	8.28	5.59
Return on Equity (ROE)	-15.76%	-15.76%	-8.31%	-7.08%	-2.34%	-22.00%
Return on Assets (ROA)	-9.13%	-9.13%	-5.67%	-5.00%	-3.83%	-6.58%
Return on Invested Capital (ROIC)	-41.86%	-35.62%	-21.39%	-18.81%	-15.26%	-23.88%
Return on Capital Employed (ROCE)	-18.60%	-18.60%	-10.40%	-8.70%	-6.90%	-13.30%
Earnings Yield	-8.96%	-9.40%	-5.05%	-4.15%	-1.17%	-18.62%
FCF Yield	-8.39%	-8.80%	-3.07%	0.75%	-5.83%	-3.39%
Buyback Yield / Dilution	-	-	-	-0.04%	-0.81%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.